Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Telesis Bio Inc (TBIO)

Telesis Bio Inc (TBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Emergent Biosolutions (EBS) Reports Q1 Loss, Tops Revenue Estimates Zacks - Tue May 9, 2023

Emergent Biosolutions (EBS) delivered earnings and revenue surprises of -89.82% and 15.61%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

EBS : 2.18 (-4.80%)
TBIO : 0.3213 (-0.68%)
Beat the Market the Zacks Way: Hershey's, Telesis Bio, General Mills in Focus Zacks - Mon Apr 17, 2023

Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.

HSY : 188.14 (+0.57%)
GIS : 71.61 (+1.12%)
TSCO : 258.13 (+0.85%)
AZO : 2,988.51 (+0.93%)
YPF : 20.16 (-3.40%)
TBIO : 0.3213 (-0.68%)
BDORY : 10.5300 (+0.38%)
AXON : 302.41 (+0.28%)
NOBL : 97.79 (-0.05%)
PD : 20.76 (-1.38%)
GEHC : 86.72 (+0.56%)
Telesis Bio (TBIO) Reports Q4 Loss, Tops Revenue Estimates Zacks - Tue Mar 21, 2023

Telesis Bio (TBIO) delivered earnings and revenue surprises of 12.50% and 5.21%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

TBIO : 0.3213 (-0.68%)
RETA : 172.36 (+0.02%)
Paratek Pharmaceuticals (PRTK) Reports Q4 Loss, Tops Revenue Estimates Zacks - Thu Mar 16, 2023

Paratek (PRTK) delivered earnings and revenue surprises of -1,300% and 33.06%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

PRTK : 2.23 (+1.83%)
TBIO : 0.3213 (-0.68%)
Should You Buy Telesis Bio (TBIO) After Golden Cross? Zacks - Tue Mar 14, 2023

When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?

TBIO : 0.3213 (-0.68%)
Evogene (EVGN) Reports Q4 Loss, Tops Revenue Estimates Zacks - Thu Mar 9, 2023

Evogene (EVGN) delivered earnings and revenue surprises of 66.67% and 20%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

EVGN : 0.6695 (+1.49%)
TBIO : 0.3213 (-0.68%)
Acadia Pharmaceuticals (ACAD) Reports Q4 Loss, Tops Revenue Estimates Zacks - Mon Feb 27, 2023

Acadia (ACAD) delivered earnings and revenue surprises of -4% and 1.55%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

ACAD : 16.59 (-0.90%)
TBIO : 0.3213 (-0.68%)
Translate Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) Globe NewsWire - Wed Sep 8, 2021

LEXINGTON, Mass., Sept. 08, 2021 (GLOBE NEWSWIRE) -- Translate Bio (Nasdaq: TBIO), a clinical-stage messenger RNA (mRNA) therapeutics company developing a new class of potentially transformative medicines...

TBIO : 0.3213 (-0.68%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates TGRF, SIC, SAFM, TBIO; Shareholders are Encouraged to Contact the Firm AccessWire - Thu Aug 26, 2021

NEW YORK, NY / ACCESSWIRE / August 26, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: TGR Financial, Inc. (OTCQX:TGRF) concerning potential...

TGRF : 15.5500 (+1.83%)
SIC : 14.49 (+0.07%)
SAFM : 204.00 (-2.51%)
TBIO : 0.3213 (-0.68%)
INVESTIGATION: Halper Sadeh LLP Investigates CMO, TBIO, SIC, SAFM; Shareholders are Encouraged to Contact the Firm Globe NewsWire - Tue Aug 17, 2021

NEW YORK, Aug. 17, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

CMO : 6.50 (+2.52%)
TBIO : 0.3213 (-0.68%)
SIC : 14.49 (+0.07%)
SAFM : 204.00 (-2.51%)

Barchart Exclusives

1 Stock to Profit from the U.S. Infrastructure Spending Bonanza Barchart - 46 minutes ago
The poor state of U.S. infrastructure is why the government has allocated trillions of dollars in federal funding towards upgrading it. While this spending is good for the country, it will be great for the companies that supply construction materials - like aggregates and concrete giant Vulcan Materials. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot